Table 2 Correlation between FZD6 expression and clinicopathological features of UCB patients
Parameters Total | Group | Total | FZD6 expression | P value | |
|---|---|---|---|---|---|
High | Low | ||||
Gender | Male | 79 (75%) | 56 (53%) | 23 (22%) | 0.682 |
Female | 27 (25%) | 18 (17%) | 9 (8%) | ||
Age (years) | < 60 | 37 (35%) | 25 (24%) | 12 (11%) | 0.713 |
≥ 60 | 69 (65%) | 49 (46%) | 20 (19%) | ||
Tumor size (cm) | < 3 cm | 42 (40%) | 24 (23%) | 18 (17%) | 0.021 * |
≥ 3 cm | 64 (60%) | 50 (47%) | 14 (13%) | ||
Multiplicity | Single | 59 (56%) | 40 (38%) | 19 (18%) | 0.613 |
Multiple | 47 (44%) | 34 (32%) | 13 (12%) | ||
Histological grade | L | 48 (45%) | 26 (25%) | 22 (21%) | 0.003 ** |
H | 58 (55%) | 48 (45%) | 10 (9%) | ||
Tumor stage T | Ta,T1 | 26 (25%) | 11 (10%) | 15 (14%) | 0.001 ** |
T2-T4 | 80 (75%) | 63 (59%) | 17 (16%) | ||
Lymph nodes metastasis | NO | 92 (87%) | 63 (59%) | 29 (27%) | 0.650 |
YES | 14 (13%) | 11 (10%) | 3 (3%) | ||